STAMFORD, Conn., Feb. 20, 2020 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, today announced that the Company will host a conference call and live audio webcast on Thursday, February 27, 2020, at 4:30 p.m. ET to report fourth quarter and full year 2019 financial results and provide a corporate update.
CV Sciences, Inc. Applauds USDA’s Establishment of the U.S. Domestic Hemp Production Program
October 30, 2019
Puration, Inc. Joins The Stock Day Podcast to Discuss Their Expansion Into The CBD Beverage Industry
October 22, 2019
GET LISTED
Thank you for your sharing. I am worried that I lack creative ideas. It is your article that makes me full of hope. Thank you. But, I have a question, can you help me?
I don’t think the title of your article matches the content lol. Just kidding, mainly because I had some doubts after reading the article.